Feb. 6 at 6:03 PM
$PFE gearing up for a major pivot — obesity & oncology could be the 2026 growth engine 🚀
The company is lining up 20 pivotal studies in 2026, following
$9B in 2025 M&A, signaling a serious commitment to rebuilding its pipeline around these two high-impact areas.
See how this pipeline push could reshape Pfizer’s future 👉 https://www.zacks.com/stock/news/2837062/pfizer-bets-big-on-obesity-and-oncology-with-2026-pipeline-push?cid=sm-stocktwits-2-2837062-teaser-32424&ADID=SYND_STOCKTWITS_TWEET_2_2837062_TEASER_32424